- A comparative cell-based high throughput screening strategy for the discovery of selective tyrosine kinase inhibitors with anticancer activity. Stratowa, C., Baum, A., Castañon, M.J., Dahmann, G., Himmelsbach, F., Himmler, A., Loeber, G., Metz, T., Schnitzer, R., Solca, F., Spevak, W., Tontsch, U., von Rüden, T. Anticancer Drug Des. (1999)